|
Contact: Patricia A. Spinella Investor Relations (201) 847-5453 Email: patricia_spinella@bd.com FRANKLIN LAKES, N.J.--(BUSINESS WIRE)--Oct. 15, 2003--BD (Becton, Dickinson and Company) (NYSE:BDX) will announce its fourth fiscal quarter and year-end results at 6:00 a.m. (ET) on Thursday, November 6, 2003. A conference call regarding these results will be held on Thursday, November 6, 2003 at 8:30 a.m. (ET). Investors and the general public are invited to listen to a live webcast of the conference call at www.bd.com/investors. A replay of the webcast will be available through the close of business on November 13, 2003. BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. For the fiscal year ended September 30, 2002, BD reported total revenues of $4.033 billion.
|